Zobrazeno 1 - 10
of 153
pro vyhledávání: '"Gertrude B. Elion"'
Autor:
Gertrude B. Elion, George H. Hitchings
Publikováno v:
Annals of the New York Academy of Sciences. 129:799-803
Autor:
Varsha Gandhi, Beverly S. Mitchell, C. Stephens, Joanne J. Lager, M.J. Keating, J.P. Hodge, T. Krenitsky, Joanne Kurtzberg, T.J. Ernst, Gertrude B. Elion, J. Levin, David F. Kisor
Publikováno v:
Journal of Clinical Oncology. 23:3396-3403
Purpose A phase I study was conducted to determine the maximum-tolerated dose (MTD), toxicity profile, and pharmacokinetics of a novel purine nucleoside, nelarabine, a soluble prodrug of 9-beta-D-arabinosylguanine (araG; Nelarabine), in pediatric and
Autor:
Stewart P. Johnson, Stephen T. Keir, Peter J. Houghton, Darell D. Bigner, Gertrude B. Elion, Henry S. Friedman, Robert C. Castellino
Publikováno v:
Cancer Chemotherapy and Pharmacology. 45:345-349
Purpose: To further evaluate the activity of irinotecan (CPT-11) plus 1,3-bis-(chloroethyl)-1-nitrosourea (BCNU) in the treatment of central nervous system tumor-derived xenografts in athymic nude mice. Methods: We report studies evaluating the sched
Autor:
Lilia M. Beauchamp, Howard J. Schaeffer, Gertrude B. Elion, Paulo de Miranda, James A. Fyfe, Phillip A. Furman
Publikováno v:
Reviews in Medical Virology. 9:147-153
Autor:
Darell D. Bigner, Henry S. Friedman, Peter J. Houghton, Colvin Om, C B Hare, Stephen T. Keir, Gertrude B. Elion, C A Coggins
Publikováno v:
Cancer Chemotherapy and Pharmacology. 41:485-490
Two major obstacles in the treatment of patients with central nervous system malignancies are drug resistance and host toxicity. The goal of combination chemotherapy is to achieve therapeutic effects that are more favorable than using a single drug a
Autor:
Henry S. Friedman, Owen W. Griffith, S. L. Marcelli, William P. Petros, Colvin Om, Darell D. Bigner, Stephen T. Keir, C B Hare, Francis Ali-Osman, Gertrude B. Elion
Publikováno v:
Cancer Chemotherapy and Pharmacology. 40:409-414
Busulfan is an alkylating agent commonly used in the treatment of chronic myelogenous leukemia and in combination with cyclophosphamide in preparation for allogeneic bone marrow transplantation. Serial treatment of a childhood high-grade glioma xenog
Publikováno v:
Trends in Pharmacological Sciences. 18:3-7
Autor:
Charles N. Pegram, Darell D. Bigner, Daniel Wellner, Henry S. Friedman, Gertrude B. Elion, Kate Moynihan, Owen W. Griffith, Craig J. Reist
Publikováno v:
Cancer Chemotherapy and Pharmacology. 39:179-186
These studies evaluated the efficacy of sequential pretreatment with L-amino acid oxidase (LOX) and LOX antiserum in the modulation of melphalan activity against intracranial glioma in athymic nude mice. LOX produced statistically significant (P0.01)
Autor:
Mark W. Dewhirst, Gertrude B. Elion, Henry S. Friedman, Sharon M. Castellino, Darell D. Bigner, E. T. Ong, Robert L. Page, S. L. Marcelli
Publikováno v:
British Journal of Cancer
Flunarizine, a diphenylpiperazine calcium channel blocker, is known to increase tumor blood flow. It also interferes with calmodulin function, repair of DNA damage and drug resistance associated with P-glycoprotein. Flunarizine was tested for its abi
Autor:
Michael L. Graham, Gertrude B. Elion, R H Aaron, Darell D. Bigner, Henry S. Friedman, O M Colvin, Stephen T. Keir
Publikováno v:
Cancer Chemotherapy and Pharmacology. 35:127-131
We evaluated the antitumor activity of busulfan against a panel of tumor cell lines and xenografts in athymic nude mice derived from childhood high-grade glioma, adult high-grade glioma, ependymoma, and medulloblastoma. Busulfan displayed similar act